Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study

• By

• Yi Zhang

• Hu Zhou

• Shanshan Suo

• Junling Zhuang

• Linhua Yang

• Aili He

• Qingchi Liu

• Xin Du

• Sujun Gao

• Yarong Li

• Yan Li

• Yuqing Chen

• Wen Wu

• Huanling Zhu

• Guangsheng He

• Mei Hong

• Qian Jiang

• Zhongxing Jiang

• Hongmei Jing

• Jishi Wang

• Na Xu

• Lingling Yue

• Cuiping Zheng

• Zeping Zhou

• Chenghao Jin

• Xin Li

• Lin Liu

• Yajing Xu

• Dengshu Wu

• Feng Zhang

• Jin Zhang

• Liqing Wu

• Hewen Yin

• Binhua Lv

• Zhijian Xiao

• Jie Jin

• December 18, 2024

• 0 min

• Blood Cancer Journal